Saturday 17 October 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
1,006.92
8.28
+0.83%
Follow MCK
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
23.94 | 23.49 | 22.40 | 20.13 |
P/S ratio |
0.25 | 0.25 | 0.27 | 0.22 | |
P/FCF ratio |
15.94 | 10.48 | 19.77 | 14.60 | |
P/Operating CF |
39.58 | 82.03 | 31.27 | (407.68) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.27 | 0.28 | 0.28 | 0.24 | |
EV/EBITDA |
17.72 | 17.32 | 16.51 | 13.68 | |
EV/Operating CF |
15.24 | 10.47 | 18.62 | 14.49 | |
EV/FCF |
17.42 | 11.38 | 21.18 | 16.16 | |
Quick Ratio |
0.47 | 0.46 | 0.48 | 0.50 | |
Current Ratio |
0.88 | 0.88 | 0.85 | 0.89 | |
Net Debt/EBITDA |
5.55 | 4.82 | 3.26 | 6.36 | |
Debt/Assets |
15.28% | 13.85% | 14.11% | 16.74% | |
Debt/Equity |
(9.49) | (12.94) | (6.54) | (3.83) | |
Asset Turnover |
4.94 | 5.13 | 5.12 | 4.85 | |
Operating CF/Net income |
2.18 | 1.04 | 2.03 | (0.36) | |
Capex/Depreciation |
(1.04) | (0.93) | (0.94) | (0.78) | |
Interest Coverage |
19.01 | 25.70 | 35.25 | 17.13 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.01% | 1.91% | 1.87% | 2.15% | |
Intangible Assets out of Total Assets |
0.18 | 0.18 | 0.19 | 0.17 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.27) | (0.25) | (0.25) | (0.33) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.18% | 4.26% | 4.47% | 4.97% | |
Free Cash Flow Yield |
6.27% | 9.54% | 5.06% | 6.85% | |
Revenue per Share |
831.85 | 861.67 | 779.09 | 887.78 | |
Operating CF per Share |
19.52 | 10.00 | 27.68 | (1.85) | |
Capex per Share |
(1.58) | (1.42) | (1.50) | (1.28) | |
Free Cash Flow per Share |
17.94 | 8.58 | 26.18 | (3.13) | |
Cash per Share |
32.29 | 24.02 | 32.16 | 43.50 | |
Shareholders Equity per Share |
(10.93) | (7.31) | (14.38) | (32.55) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(10.93) | (7.31) | (14.38) | (32.55) | |
Free Cash Flow |
2,224.00 | 1,057.00 | 3,236.00 | (372.00) | |
Working Capital |
(8,144.00) | (8,434.00) | (9,807.00) | (7,519.00) | |
Capital Expenditures |
(196.00) | (175.00) | (185.00) | (152.00) | |
Net Current Asset Value |
(25,628.00) | (25,394.00) | (26,890.00) | (29,357.00) | |
EV/EBIT |
19.90 | 19.42 | 18.45 | 15.29 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
18.22 | 17.88 | 17.22 | 13.81 | |
| Other line items | |||||
Average Receivables |
26,778.00 | 27,022.00 | 26,814.00 | 29,237.00 | |
Average Payables |
57,127.50 | 55,186.00 | 57,651.50 | 60,796.00 | |
Average Inventory |
25,155.00 | 25,452.00 | 23,604.00 | 25,662.00 | |
Average Assets |
78,294.50 | 77,635.50 | 78,731.50 | 84,820.50 | |
Average Common Equity |
(1,998.50) | (1,802.50) | (1,735.50) | (2,726.00) |
Columns are period end dates